Marino Garcia, CEO AND PRESIDENT at Dianthus Therapeutics, Inc. /DE/ (DNTH), sold 166,000 shares at $107.49 ($17.9M) on 2026-08-07, disclosed to the SEC on 2026-08-07.
Scheduled sale ($17.9M) by CEO AND PRESIDENT under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $107.49 | 10,384 | $1.1M | 6.2% |
| 2 | $107.96 | 104,091 | $11.2M | 62.6% |
| 3 | $108.05 | 23,907 | $2.6M | 14.4% |
| 4 | $108.72 | 21,909 | $2.4M | 13.3% |
| 5 | $109.10 | 2,373 | $259K | 1.4% |
| 6 | $110.02 | 2,536 |
| $279K |
| 1.6% |
| 7 | $110.76 | 800 | $89K | 0.5% |
| Total | $108.11 avg | 166,000 | $17.9M | 100% |